StockOtters
StockOttersSupply Chain Map
Hansoh Pharmaceutical Group Company Limited logo

Hansoh Pharmaceutical Group Company Limited

3692.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
1,594
Cost of Revenue
144
Gross Profit
1,450
Gross Margin
91.0%
Operating Income
524
Operating Margin
32.9%
Net Income
568
Net Margin
35.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
556
EBITDA Margin
34.9%

2023

12/31/2023

Revenue
1,313
Cost of Revenue
134
Gross Profit
1,179
Gross Margin
89.8%
Operating Income
369
Operating Margin
28.1%
Net Income
426
Net Margin
32.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
546
EBITDA Margin
41.6%

2022

12/31/2022

Revenue
1,220
Cost of Revenue
113
Gross Profit
1,107
Gross Margin
90.7%
Operating Income
347
Operating Margin
28.5%
Net Income
336
Net Margin
27.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
381
EBITDA Margin
31.2%

2021

12/31/2021

Revenue
1,292
Cost of Revenue
113
Gross Profit
1,178
Gross Margin
91.2%
Operating Income
377
Operating Margin
29.2%
Net Income
353
Net Margin
27.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
401
EBITDA Margin
31.0%

2020

12/31/2020

Revenue
1,130
Cost of Revenue
104
Gross Profit
1,025
Gross Margin
90.8%
Operating Income
360
Operating Margin
31.9%
Net Income
334
Net Margin
29.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
389
EBITDA Margin
34.4%